BlackRock Advisors’s CorMedix CRMD Stock Holding History

BlackRock Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Hold	1,518	–	–	﹤0.01%	3544
2016 Q3	$19K	Hold	1,518	–	–	﹤0.01%	3463
2016 Q2	$15K	Sell	1,518 -1,683	-53%	-$25.6K	﹤0.01%	3506
2016 Q1	$42K	Hold	3,201	–	–	﹤0.01%	3206
2015 Q4	$32K	Sell	3,201 -1,467	-31%	-$16.9K	﹤0.01%	3352
2015 Q3	$46K	Sell	4,668 -9	-0.2%	-$139	﹤0.01%	3334
2015 Q2	$91K	Buy	+4,677	New	+$160K	﹤0.01%	3200

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's CRMD Position: Q4 2016 in Review

BlackRock Advisors held its CorMedix (CRMD) position steady in Q4 2016 at 1,518 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3544.

BlackRock Advisors first reported a position in CRMD in Q2 2015 and has held it in 7 quarters since. The position peaked at $91K in Q2 2015. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

BlackRock Advisors held 1,518 shares of CorMedix worth $12K as of Q4 2016.
BlackRock Advisors left its CorMedix share count unchanged in Q4 2016.
CorMedix made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3544 holding.
BlackRock Advisors first reported a position in CorMedix in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's CorMedix position peaked at $91K in Q2 2015.
38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.